Burkholderia mallei is a gram-negative, nonmotile, aerobic, non-spore-forming bacillus and an obligate animal parasite. It is an intracellular pathogen that can cause the disease glanders in solipeds (horses, donkeys, and mules), humans (2, 18, 35) , and experimental animals, such as hamsters (12) and mice (11) . B. mallei is currently a potential bioterrorism threat (5) and causes severe disease in humans. Few natural cases of glanders have been reported; the last recorded human case was diagnosed in a U.S. Government laboratory worker following a systemic febrile illness (35) . The general acute symptoms include high fever (2) and respiratory distress (35) , as well as swollen lymph nodes and chest pain (18, 35) . Abscesses in the liver and spleen are characteristic of the disease in both humans (35) and experimental mouse models of infection (unpublished observations).
Following aerosol challenge BALB/c mice develop a disease similar to acute human glanders (23) . However, BALB/c mice are relatively resistant to B. mallei following intraperitoneal challenge (24) and develop an acute disease only with doses of Ն10 7 CFU (11). At lower doses, an infection similar to the infection observed in chronic human glanders develops. This infection is characterized by bacterial colonization of organs, including the spleen, liver, lungs, and blood (11) , and survival for several months postinfection with the appearance of chronic foci of infection (24) . Pathological changes to the liver and spleen and inflammatory infiltrates are observed early in the infection (11) , and abscesses develop within 2 weeks after infection (unpublished observations). B. mallei is a close phylogenetic relative of Burkholderia pseudomallei, the causative agent of human melioidosis, an important public health problem in Southeast Asia and northern Australia (38) . The immune response to B. pseudomallei has been well characterized, in contrast to the response to B. mallei, for which there is little information regarding host immune responses. It is not known whether there are parallels in the abilities of these two organisms to stimulate host immune responses.
Control of gamma interferon (IFN-␥) production is crucial for regulating cell-mediated immunity responses to intracellular infection (32) . Following infection with the intracellular pathogens B. pseudomallei (16) and Listeria monocytogenes (30) , host resistance is mediated by IFN-␥. In other infection models, interleukin-12 (IL-12), IL-18, and the newly discovered cytokine IL-27 are involved in IFN-␥ production (31) . IL-12, a proinflammatory cytokine released by macrophages during the early stages of infection, has an essential role in inducing production of IFN-␥ from T cells and NK cells (14, 31) . This cytokine is composed of two subunits (p35 and p40) and has been shown to be important in host defense against a range of intracellular pathogens, including Mycobacterium tuberculosis (10) and Leishmania major (17) . In other intracellu-lar infections, including Francisella tularensis infections (9), the p40 subunit but not the p35 subunit is important for protection against infection. IL-18, a proinflammatory cytokine secreted by activated antigen-presenting cells, acts synergistically with IL-12 to induce the production of IFN-␥ during infection with a number of pathogens, including B. pseudomallei (16) , L. monocytogenes (26) , and Mycobacterium leprae (13) . IL-18 is also essential in host defense during L. monocytogenes infection through IFN-␥-independent induction of NO and tumor necrosis factor alpha (TNF-␣) from macrophages (26) . IL-27, produced by antigen-presenting cells, is also involved in IFN-␥ production from naïve CD4 ϩ T cells in vitro and acts synergistically with IL-12 (29) ; however, little is known about its role in induction of IFN-␥ in vivo.
The mechanisms of cell-mediated immunity to B. mallei are currently not known. Therefore, our goal was to characterize the patterns of cytokine expression and release during early B. mallei infection in BALB/c mice. A strong IFN-␥ response, accompanied by expression of IL-18, IL-12, IL-27, and IL-6, was observed within 24 h after B. mallei infection. IFN-␥ was found to be essential in innate host immune responses to B. mallei infection. IL-12 was critical for inducing IFN-␥ in response to heat-killed B. mallei in vitro, and IL-18 was involved in this induction. In vitro studies revealed that the main cellular IFN-␥ sources are NK cells and CD8 ϩ T cells. The data presented in this paper provide novel, valuable information on protective host immune responses to B. mallei and should assist in the development of an effective vaccine against this pathogen.
MATERIALS AND METHODS
B. mallei. B. mallei strain ATCC 23344 (American Tissue Culture Collection) was used for all challenge experiments. All work involving live B. mallei was carried out under Advisory Committee on Dangerous Pathogens containment level 3. Bacterial cells were grown in nutrient broth at 37°C for 48 h. Cells were harvested by centrifugation and washed three times in phosphate-buffered saline (PBS) before they were resuspended in 0.1 volume of PBS. The number of bacteria present was calculated by spreading 0.25-ml aliquots of diluted culture onto Congo red plates and incubating the plates at 37°C for 48 h.
For in vitro stimulation assays, bacteria were killed by heat treatment in a water bath at 70°C for 3 h with occasional gentle shaking, and each suspension was checked for sterility by inoculating 5-ml portions of nutrient broth with 0.5-ml aliquots of the suspension ml and incubating the preparations for 7 days at 37°C. Nutrient agar plates were then inoculated with the total broth cultures to check for bacterial growth and incubated for 7 days at 37°C. If no growth occurred on agar plates, inactivation of the bacterial suspension was assumed to have occurred.
Infection of mice with B. mallei. All mice were housed in a rigid wall isolator in an Advisory Committee on Dangerous Pathogens animal containment level 3 facility. All in vivo work was carried out within the guidelines of the Animal Scientific Procedures Act, 1986. Female BALB/c mice that were 6 to 8 weeks old were purchased from Charles River (Margate, United Kingdom); 8-to 14-weekold female BALB/c IFN-␥ knockout (KO), C57BL/6 wild-type, C57BL/6 IFN-␥ KO, C57BL/6 IL-12p40 KO, and C57BL/6 IL-12p35 KO mice were bred at the London School of Hygiene and Tropical Medicine (London, United Kingdom). C57BL/6 WSX-1 (IL-27 receptor) KO mice were obtained from the University of Manchester, United Kingdom. BALB/c mice were inoculated intraperitoneally (0.1 ml) with B. mallei strain ATCC 23344 using a 0.5-ml syringe.
Bacteriological analysis of organs. Organs were dissected and passed through sterile nylon sieves into PBS, and cell suspensions (250 l) were spread onto Congo red plates and incubated at 37°C for 48 h. Average bacterial counts for each organ were calculated. Blood was removed from mice by cardiac puncture using 0.5-ml insulin syringes following Halothane anesthesia. The blood was placed into O-ring-sealed sarstedt tubes and centrifuged (13,000 rpm, 5 min). The serum was removed and stored at Ϫ20°C until a cytokine analysis was performed.
Extraction of RNA from spleens. Spleens were mashed in Trizol (0.8 ml; Invitrogen, United Kingdom) using micropestles (Eppendorf, United Kingdom) and then stored at Ϫ20°C prior to RNA extraction. Following defrosting, chloroform (0.2 ml; Sigma, United Kingdom) was added, and samples were shaken vigorously and incubated at room temperature for 5 min. Samples were centrifuged (12,000 ϫ g, 15 min), each aqueous layer was transferred into a fresh RNase-free Eppendorf tube, and the pellet was discarded. Isopropanol (0.5 ml; Sigma, United Kingdom) was added to the aqueous supernatant, and samples were mixed and incubated at room temperature for 10 min. Samples were centrifuged (12,000 ϫ g, 15 min), and each pellet was washed in 75% molecular biology grade ethanol (Sigma, United Kingdom) and centrifuged (7,000 ϫ g, 5 min). The ethanol was removed, and the RNA pellets were left to air dry and were then dissolved in nuclease-free water (0.1 ml) and stored at Ϫ80°C prior to PCR analysis. DNA contamination was removed from RNA samples using a DNA-free kit (Ambion, United Kingdom), and samples were stored at Ϫ80°C prior to analysis.
Real-time reverse transcriptase PCR. RNA samples were reverse transcribed using the GeneAmp 9700 PCR system (Perkin-Elmer, United Kingdom) following treatment with an Omniscript kit (QIAGEN, United Kingdom), random primers, and recombinant RNasin RNase inhibitor (Promega, United Kingdom). cDNA samples were stored at Ϫ20°C prior to analysis. Real-time reverse transcriptase PCR (RT-PCR) was performed using a TaqMan 7000 PCR machine (Applied Biosystems, United Kingdom). Expression of murine IFN-␥, IL-12p35, IL-12p40, and IL-6 and the internal 18S RNA control gene was detected using predeveloped assay reagents (Applied Biosystems, United Kingdom). Assay-onDemand gene expression products (Applied Biosystems, United Kingdom) were used to detect murine IL-18 and the murine IL-27 p28 subunit. TaqMan universal PCR master mixture (Applied Biosystems, United Kingdom) and nucleasefree water (Promega, United Kingdom) were used in all TaqMan PCRs. PCRs were performed in triplicate, and the 18S RNA internal control was included for each sample.
Analysis of RT-PCR data. Real-time RT-PCR data were analyzed using the ABI PRISM 7000 analysis software (Applied Biosystems, United Kingdom) and the comparative threshold cycle (C T ) method. Differences in the amount of transcribed RNA for each sample were accounted for by subtracting the C T value obtained for 18S RNA from the C T value obtained for each cytokine to obtain ⌬C T , which allowed actual changes in gene expression to be identified.
In vitro stimulation of murine spleen cells. Uninfected mice were killed by cervical dislocation, the spleens were removed aseptically, and single-cell suspensions were prepared. Erythrocytes were lysed using red blood cell lysis buffer (Sigma, United Kingdom), the resulting cell suspensions were washed, and the concentrations were adjusted to 5 ϫ 10 6 cells/ml. The cells were suspended in RPMI 1640 medium (Life Technologies, United Kingdom) supplemented with 10% fetal calf serum, 200 U/ml penicillin, 200 g/ml streptomycin, and L-glutamine (10 mM) and incubated with 0.1 ml/well of a preparation containing 1 ϫ 10 6 heat-killed B. mallei cells/ml or a medium control in 96-well flat-bottom cultured plates (5% CO 2 , 37°C) for 24 h. Anti-IL-18 receptor antibodies (TC30-28E3; Anne O'Garra, National Institute for Medical Research, London, United Kingdom; originally made at DNAX Research Institute, Palo Alto, CA [26] ) or isotype-matched control antibodies (Mac 5; immunoglobulin G2b [IgG2b]) were added in vitro to wild-type C57BL/6 spleen suspensions at a dose of 10 g/ml at the same time that heat-killed B. mallei was added.
For analysis of secreted cytokines, supernatants were removed from wells after 24 h and were stored at Ϫ20°C prior to analysis with a cytometric bead array (CBA). For analysis of intracellular IFN-␥ by flow cytometry, cytokine secretion in spleen cell cultures stimulated with heat-killed B. mallei or medium was blocked by addition of brefeldin A (0.01 mg/ml) 3 h before cells were harvested for analysis of cytokine production at 21 h after stimulation.
Flow cytometry analysis of intracellular IFN-␥ and cell surface marker staining. Spleen cells harvested following in vitro stimulation were washed and stained with fluorescein isothiocyanate-labeled cell surface markers obtained from Sigma, United Kingdom, including anti-CD4 (H129.19, rat IgG2a), anti-CD8a (53-6.7, rat IgG2a), and anti-TCR␣␤ (H57-597, hamster Ig), and from Pharmingen, United Kingdom, including anti-TCR␥␦ (GL3, hamster Ig), anti-pan NK cells (DX5, rat IgM), anti-NK1.1 (PK136, rat IgG2a), anti-CD44 (IM7, rat IgG2b), and CD3-PE-Cy5 (145-2C11, recombinant IgG1). Isotype-matched control antibodies were included in each analysis. Cells were washed, fixed, permeabilized, and incubated with phycoerythrin-labeled anti-IFN-␥ (XMG1.2, rat IgG1; Pharmingen). Up to 100,000 events were collected, and viable cells were gated by forward and side scatter and analyzed using a FACScan flow cytometer with CellQuest software (Becton Dickinson, Mountain View, CA) or using a Beckman Coulter EPICS XL flow cytometer with Winlist software.
Cytokine protein analysis. Cell culture supernatants at containment level 2 were analyzed to determine the presence of cytokines using mouse inflammation CBA kits (Becton Dickinson, United Kingdom) according to the manufacturer's instructions. Sera obtained from infected animals at containment level 3 were analyzed using CBA kits according to the manufacturer's instructions, except that in the final step the pellet of cytokine beads was resuspended in 6% paraformaldehyde (0.5 ml) and refrigerated for 24 h prior to analysis to ensure that the sample was sterile. Samples were analyzed using a FACScan flow cytometer (Becton Dickinson, United Kingdom), and BD CBA software was used for data analysis.
Statistical analysis. Data obtained during the real-time RT-PCR analysis and the analysis of serum cytokines were nonparametric; therefore, data are presented below as medians Ϯ 99% confidence intervals. A Kruskal-Wallis test was performed with the data, followed by a Mann-Whitney U test. A P value of Ͻ0.01 indicated statistical significance in comparisons with uninfected control mice. A one-way analysis of variance was performed in order to compare the responses of wild-type and knockout mice using cytokine data obtained during in vitro stimulation assays with heat-killed B. mallei, and a Student t test was performed with bacterial count data obtained during B. mallei infection in vivo. A P value of Ͻ0.05 indicated statistical significance.
RESULTS
Bacterial colonization of the spleen. During the first 7 days of infection, BALB/c mice did not die as a result of infection with 1 ϫ 10 6 CFU B. mallei and showed no ruffling of fur or any other overt signs of disease. The spleens of all mice were colonized uniformly within 5 h after infection. At 24 h postinfection, between 10 2 and 10 3 CFU were identified in the spleens of all mice except one mouse, in which 10 CFU was detected. Variability in bacterial counts occurred from days 3 to 7 postinfection, although the median bacterial burden in the spleen remained between 10 2 and 10 3 CFU for the first 7 days of infection (Fig. 1) .
Cytokine mRNA expression in the spleen. We aimed to determine the type 1 cytokine profiles induced during the early stages of intraperitoneal B. mallei infection (1 ϫ 10 6 CFU) in the spleen. Cytokine responses were assessed during the first 7 days of infection by examining mRNA expression by real-time RT-PCR. At 5 h postinfection, a twofold increase in IL-18 expression (P Ͻ 0.01) was detected in B. mallei-infected animals compared to the expression in naïve animals ( Fig. 2A) . No significant change in the expression of any other cytokine was observed at this time. By 24 h postinfection, the expression of IFN-␥ and IL-27 had increased (P Ͻ 0.01) to levels above the control expression levels (49-fold increase for IFN-␥ and 14-fold increase for IL-27) (Fig. 2B) . A 35-fold increase in IL-6 expression (P ϭ 0.0124) and increased IL-12p35 expression were also detected ( Fig. 2A and B) . Expression of IL-18 and expression of IL-12p40 were not elevated compared to the expression in uninfected animals at 24 h postinfection ( Fig.  2A) . Between 3 and 7 days postinfection, the levels of cytokine expression decreased to preinfection levels for IFN-␥, IL-6, and IL-27 and were not significantly higher than the levels of cytokine expression in uninfected controls ( Fig. 2A and B) .
At 5 h postinfection, the bacterial numbers were uniform in the six animals investigated (Fig. 1) , and this corresponded with uniform cytokine expression at this time ( Fig. 2A and B) . No increase in production of TNF-␣ or IL-12p70 was detected at any time during the infection (data not shown). Increases (P Ͻ 0.01) in serum levels of MCP-1, IL-6, and IFN-␥ were observed within 5 h after infection compared with the levels in naïve animals ( Fig. 3) . At 24 h postinfection, the serum IFN-␥ levels were maximal and were higher (P Ͻ 0.001) than the levels found in uninfected mice. Serum MCP-1 and IL-6 levels also peaked 24 h postinfection at values higher (P Ͻ 0.01) than the values in control animals. Between days 3 and 7 postinfection, no significant increases above the values for naïve mice were detected for any of the cytokines assayed.
B. mallei infection of IFN-␥ knockout and IL-12 knockout mice. The importance of the IFN-␥ peak observed during the initial stages of B. mallei infection in BALB/c mice was investigated. IFN-␥ knockout mice with BALB/c and C57BL/6 backgrounds were used to assess the effect of the genetic background on the importance of IFN-␥ during B. mallei infection as knockout mice during in vitro studies originated from a C57BL/6 mouse strain. Wild-type BALB/c mice challenged with the both a low dose (1 ϫ 10 2 CFU) and a high dose (1 ϫ 10 6 CFU) of B. mallei survived for the duration of the experiment (Fig. 4A) . However, most BALB/c IFN-␥ KO mice (9 of 10) died 2 days after infection following challenge with a high dose of B. mallei (Fig. 4A) . Challenge with a low dose of B. mallei caused six of seven IFN-␥ KO BALB/c mice to die within 5 days after infection (Fig. 4A) . Wild-type C57BL/6 mice challenged with both the low dose (41 CFU) and the high dose (4.1 ϫ 10 4 CFU) of B. mallei survived for the duration of the experiment (Fig. 4B) . Following challenge with a high dose of B. mallei, all six IFN-␥ KO mice with a C57BL/6 background died 2 days postinfection (Fig. 4B) , and all six IFN-␥ KO C57BL/6 mice challenged with a low dose of B. mallei died within 3 days after infection (Fig. 4B) . Analysis of the bacterial burdens in the organs of C57BL/6 mice that received the low dose revealed significantly higher numbers of bacteria, including 10 6 -fold-higher counts in the spleen and liver and 10 3 -foldhigher counts in the lung compared with the counts in infected wild-type mice (Fig. 5) . This demonstrated that the early IFN-␥ response detected in vivo following B. mallei infection is critical for protection in both BALB/c and C57BL/6 mice.
The importance of IL-12 during B. mallei infection was investigated by using IL-12p40 knockout C57BL/6 and wild-type mice infected with a high dose (4.1 ϫ 10 4 CFU) of B. mallei. IL-12p40 KO mice (n ϭ 6) succumbed to infection between days 6 and 27 after infection. In comparison, wild-type mice did not die as a result of the infection (Fig. 4B) .
Cellular sources of IFN-␥ induced by B. mallei in vitro.
To determine the number of heat-killed bacteria required for optimal IFN-␥ induction by C57BL/6 splenocytes, a dose range study was performed (Fig. 6) . After 24 h of incubation intracellular IFN-␥ production by splenocytes was assessed using flow cytometry. The optimal dose of heat-killed B. mallei was found to be 1 ϫ 10 6 CFU (Fig. 6 ). This contrasted with the optimal dose of heat-killed B. pseudomallei (positive control) (21), which was 5 ϫ 10 5 CFU (Fig. 6 ). To identify the cellular source of IFN-␥ generated in response to B. mallei, splenocytes from uninfected C57BL/6 mice were stimulated with a predetermined optimal concentration of heat-killed bacteria (1 ϫ 10 6 cells/ml) for 24 h (data not shown), and the intracellular IFN-␥ was analyzed by flow cytometry. The predominant cell population involved in IFN-␥ production was identified as NK1.1 ϩ cells (Fig. 7A) . IFN-␥ was also detected in several T-cell subsets. The T-cell subsets responsible for IFN-␥ production were CD8 ϩ T cells and TCR␥␦ T cells (Fig. 7B and C) . No increase in IFN-␥ production was detected in the CD4 ϩ T-cell population compared with the production in controls that received only medium (Fig. 7D) .
Role of cytokines in B. mallei-induced IFN-␥ production in vitro. The role of the cytokines IL-12p35, IL-12p40, IL-18, and IL-27 in inducing IFN-␥ production was investigated using either neutralizing monoclonal antibodies or KO mice. Stimulation of splenic cultures from IL-12p35 KO or IL-12p40 KO mice with heat-killed B. mallei did not induce an IFN-␥ response compared with the response of wild-type C57BL/6 mice, in which 3 to 5 ng/ml of IFN-␥ was detected in cell culture supernatants (Fig. 8A) . In wild-type cultures stimulated with heat-killed B. mallei, IL-12p70 was detected; this cytokine was absent in IL-12p35 KO and IL-12p40 KO spleen cultures (Fig. 8B) . Intracellular analysis of IFN-␥ in NK and T-cell populations from IL-12p35 KO and IL-12p40 KO mice confirmed the absence of an IFN-␥ response, although IFN-␥ was Following neutralization of the IL-18 receptor in spleen cells from wild-type mice, a threefold reduction in IFN-␥ production compared with the production in wild-type mice (without antibody) was observed (P Ͻ 0.05) (Fig. 9A ). There were no significant differences in IFN-␥ secretion between cell culture supernatants from WSX-1 (IL-27 receptor) KO mice and cell culture supernatants from control mice following stimulation with heat-killed B. mallei (Fig. 9B) . These data demonstrated that IL-12 is essential for IFN-␥ production in vitro in response to heat-killed B. mallei and that IL-18 is involved, but IL-27 does not play a role, in induction of IFN-␥ responses in vitro.
DISCUSSION
Previous studies have shown that B. mallei causes a chronic disease in BALB/c mice, in which there is colonization of several organs and inflammatory infiltration of macrophages and neutrophils into tissues (11) . The cytokine response to B. mallei and its relevance in host defense, however, are not currently understood. We investigated the role of IFN-␥ in Our data show that B. mallei induces a strong, early IFN-␥ response in vivo in BALB/c mice, both in the spleen and systemically, as indicated by the levels in the serum. The level of serum IFN-␥ protein was elevated 5 h postinfection and peaked 24 h postinfection simultaneously with a peak in IFN-␥ mRNA expression in the spleen. This IFN-␥ response is essential for protection against B. mallei infection since disruption of the IFN-␥ gene rendered both BALB/c and C57BL/6 mice highly susceptible to B. mallei infection, with death occurring 2 to 3 days postinfection. This increased susceptibility was associated with rapid expansion of bacterial populations in the spleen, liver, and lungs, demonstrating that IFN-␥ has an essential role in controlling bacterial growth. Thus, B. mallei joins a number of other intracellular pathogens, including the closely related organism B. pseudomallei (16) and L. monocytogenes (30) , for which a rapid, innate IFN-␥ response is essential for resistance to infection.
The importance of IL-12 was assessed in IL-12p40 KO mice, and IL-12p40 was found to play an important role in in vivo protection against B. mallei infection. An increase in IL-12p35 expression was also observed throughout infection with B. mallei. Both subunits of IL-12 were found to be critical for IFN-␥ production in vitro in response to heat-killed B. mallei. The fact that IFN-␥ could not be produced in the absence of either subunit suggests that IL-12 but not IL-23 is essential for IFN-␥ production (20) . Increases in IL-18 expression 5 h postinfection suggested that IL-18 may also be involved in induction of IFN-␥ responses. We demonstrated that IL-18 is involved in (but not essential for) induction of the IFN-␥ in response to B. mallei in vitro, suggesting that the IFN-␥ response may be partially due to synergy between IL-18 and IL-12. IL-18 is important in host defense against infection by a number of intracellular pathogens, including B. pseudomallei (16, 21) , Yersinia enterocolitica (4), and L. major (27) , because it induces IFN-␥, in synergy with IL-12, from T cells (28) and NK cells (19) .
Our intracellular IFN-␥ analysis showed that NK1.1 ϩ cells, CD8 ϩ T cells, and TCR␥␦ T cells provide most of the IFN-␥ in response to B. mallei. NK1.1 ϩ cells are essential in the host defense against a number of intracellular pathogens, including L. major (34) and B. pseudomallei (16, 22) , because they produce IFN-␥. CD8 ϩ T cells, the predominant T-cell population involved in innate production of IFN-␥ in response to B. mallei, also produce IFN-␥ during infection with other pathogens, including B. pseudomallei (22) . Our data suggest that both NK cells and CD8 T cells are important in the generation of cellmediated immunity to B. mallei and that IL-12 acts on both NK cells and T cells to induce the IFN-␥ in response to heat-killed B. mallei.
The high levels of IL-27 and IL-6 expression detected in the spleen during the first 24 h of infection also indicated that these cytokines are potential inducers of IFN-␥. IL-27 is involved in IFN-␥ production during L. major infection in mice (39) but is not involved in IFN-␥ production during infection with Toxoplasma gondii (36) . Our findings demonstrated that IL-27 is not involved in IFN-␥ production in vitro in response to B. mallei, suggesting that IL-27 may have an independent role in Th1-mediated immunity during B. mallei infection. A number of studies have implicated IL-6 in the development of protective immunity by induction of IFN-␥ production during infection with the intracellular bacteria M. tuberculosis (33) and L. monocytogenes (8) . However, the role of IL-6 in induction of IFN-␥ in response to B. mallei is currently not known.
IL-6 is able to induce MCP-1 production during bacterial infection (3) and may be responsible for the high levels of MCP-1 in the host's circulation during B. mallei infection. MCP-1 is a chemokine involved in the chemoattraction of macrophages to sites of infection (7) and is important in protective immune responses during bacterial infection (15) . Macrophages are the main cell type activated by IFN-␥ and are essential for bacterial clearance during innate immune responses. The high levels of MCP-1 identified during the first 24 h of B. mallei infection implicate this chemokine in the promotion of macrophage responses for bacterial killing as macrophage influx into the spleen peaks 24 h postinfection (data not shown). MCP-1 is also involved in the recruitment of memory T cells and NK cells (6) , suggesting that MCP-1 may be a key link between IFN-␥ production and macrophage activation.
The initial burst of IFN-␥ (and potentially other cytokines) during the first 24 h after infection seems to be sufficient to control proliferation of bacterial colonies during the first week of infection, but it is not able to clear the bacteria. The downregulation of the IFN-␥ response 3 days postinfection may be caused by an immune evasive mechanism of B. mallei. IL-6 has been implicated in suppression of IFN-␥ responses during infection with M. tuberculosis (25) and is, therefore, a potential candidate for suppression of this response.
Our data begin to characterize the host immune response to B. mallei infection, adding to the very limited number of studies in which cell-mediated immune responses to B. mallei infection were investigated. There is currently no vaccine against B. mallei, and, as the host relies on IFN-␥-mediated immunity for control of infection, this may be useful in the development of vaccines and vaccination strategies against this potentially lethal agent. This possibility is supported by recent studies suggesting that Th1-like responses provide limited protection against B. mallei infection in BALB/c mice (1) and that type 1 cytokines, including IL-12 and IFN-␥, are associated with the CpG-mediated protection of low-dose aerosol B. mallei infection (37) . It is, therefore, likely that successful intervention strategies against B. mallei will exploit the cell-mediated immune responses responsible for control of the early stages of infection observed in this study.
